Even a single episode of hyperkalemia is associated with a major disease burden, a study finds.
The post De Novo Hyperkalemia Increases Risks…
[mc4wp_form id="449"]
Reductions in cardiovascular risk associated with dapagliflozin treatment in patients with type 2 diabetes are most pronounced in those who have both…
This meta-analysis aimed to determine the association between SGLT2i use and arrhythmias in patients with T2DM or HF.
The post SGLT2 Inhibitor Use…
Many believed radiocontrast exposure could be linked to long-term kidney impairment. Source: HCPLIVE.COM…
Intensive lifestyle intervention may be detrimental for overweight, obese patients with type 2 diabetes who have poor glycemic control
The post Lifestyle Changes…
“It is clear the insulin market is broken and an FTC investigation and intervention is long overdue,” the Democratic lawmakers wrote. Source:…
The therapy could offer a therapeutic option with a better safety profile, investigators said. Source: HCPLIVE.COM…
Continuing treatment results in a nearly 8% reduction in weight during a 48 week period. Source: HCPLIVE.COM…
Urinary albumin-to-creatinine ratio values are often used to guide treatment decisions as albuminuria is known to be a strong predictor of cardiovascular…
The approval is based on results from Phase 3 trials showing high efficacy in adult and pediatric populations. Source: HCPLIVE.COM…